Wyeth licenses SmartOps software

Wyeth has licensed enterprise inventory optimisation software from SmartOps.

According to the enterprise-class supply chain optimisation company, the package enables customers to achieve both a return on investment and a long-term competitive advantage, by determining the inventory and product availability plans.

These are given aggressive customer service goals and inherent uncertainties, along with time-varying data, multiple locations and inventory stage complexities.

Chief executive officer of SmartOps Sridhar Tayur said: “In the current business environment, it is even more critical that companies optimise their use of working capital while maintaining customer service.”

He added businesses are looking for a “scalable inventory planning, optimisation and analysis solution that enhances supply chain performance”.

Earlier this week, Wyeth announced data from a study of neratinib (HKI-272).

Data from tests on women with advanced HER-2-positive breast cancer suggested the therapy has antitumour activity.

It is an investigational orally-administered potent and irreversible dual inhibitor of the HER-2 and EGFR kinases.

The study involved 136 women and evaluated the safety and efficacy of a daily 240 mg oral dose of the drug.

Its primary end point was the 16-week progression-free survival rate.

Founded in 1926, Wyeth is headquartered in Madison, US and has 47,500 employees worldwide.